GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (FRA:MLI) » Definitions » 5-Year EBITDA Growth Rate

Mesa Laboratories (FRA:MLI) 5-Year EBITDA Growth Rate : 15.00% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Mesa Laboratories 5-Year EBITDA Growth Rate?

Mesa Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was €2.18.

During the past 12 months, Mesa Laboratories's average EBITDA Per Share Growth Rate was 0.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mesa Laboratories was 96.40% per year. The lowest was -19.40% per year. And the median was 11.45% per year.


Competitive Comparison of Mesa Laboratories's 5-Year EBITDA Growth Rate

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's 5-Year EBITDA Growth Rate Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's 5-Year EBITDA Growth Rate falls into.



Mesa Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Mesa Laboratories  (FRA:MLI) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Mesa Laboratories 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (FRA:MLI) Business Description

Traded in Other Exchanges
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.